New hope for older leukemia patients: targeted drug plus gentle chemo

This study tests a new treatment for older or medically frail adults with B-cell acute lymphoblastic leukemia (a fast-growing blood cancer). The treatment combines a targeted drug (blinatumomab, given as a shot under the skin) with low-intensity chemotherapy. The goal is to see if this approach is safe and effective for patients who cannot tolerate standard high-dose chemo. The study is for people aged 60+ or those 18-59 who are not healthy enough for intensive chemo.